Literature DB >> 26651955

Improved outcomes with the comprehensive stage 2 procedure after an initial hybrid stage 1.

Mark Galantowicz1, Andrew R Yates2.   

Abstract

OBJECTIVE: To report our improving institutional experience with the hybrid alternative surgical strategy for the management of hypoplastic left heart syndrome, in which hybrid stage 1 is followed by a comprehensive stage 2 procedure (removal of patent ductus arteriosus stent and pulmonary artery [PA] bands, aorta and PA reconstruction, Damus-Kaye-Stansel, atrial septectomy, Glenn).
METHODS: In this Institutional Review Board-approved retrospective review of all patients undergoing a comprehensive stage 2 procedure between January 2002 and December 2014, data were compared between the pre-protocol group (n = 64; January 2002 to March 2010) and the post-protocol group (n = 55; March 2010 to December 2014). These 2 groups flank the implementation of a perioperative management protocol to prevent PA thrombosis.
RESULTS: Pre-protocol mortality was 19% (12 of 64), with the most common mode of death involving PA thrombosis in at least 7 patients, with an urgent indication for surgery and age as contributing factors. Care modifications instituted in March 2010 included avoidance of procedures on an emergent basis or in patients aged <3 months, use of a systemic PA shunt in cases of too-small superior vena cava and/or PA, completion angiogram with a low threshold for intraoperative stenting, and postoperative anticoagulation therapy for 6 weeks. There was a significant decrease in mortality (2 of 55; 4%; P = .01), PA thrombosis (0 of 55; 0%; P = .01), and use of extracorporeal membrane oxygenation (0/55 [0%] compared with 7 of 64 [11%]; P = .01) after protocol implementation.
CONCLUSIONS: Despite the technical challenges of the comprehensive stage 2 procedure, excellent outcomes are attainable. Experience coupled with an internal quality review drove the implementation of a successful perioperative management protocol.
Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  hybrid approach; hypoplastic left heart syndrome

Mesh:

Substances:

Year:  2015        PMID: 26651955     DOI: 10.1016/j.jtcvs.2015.10.023

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

1.  High risk HLHS: hybrid approach yes, but how does it work?

Authors:  Dietmar Schranz
Journal:  Transl Pediatr       Date:  2018-07

2.  Impact of Hybrid Stage 1 Palliation for Hypoplastic Left Heart Syndrome: Histopathological Findings.

Authors:  Takashi Kido; Takaya Hoashi; Masataka Kitano; Masatoshi Shimada; Kenichi Kurosaki; Hatsue Ishibashi-Ueda; Hajime Ichikawa
Journal:  Pediatr Cardiol       Date:  2018-03-09       Impact factor: 1.655

Review 3.  Current Therapy for Hypoplastic Left Heart Syndrome and Related Single Ventricle Lesions.

Authors:  Richard G Ohye; Dietmar Schranz; Yves D'Udekem
Journal:  Circulation       Date:  2016-10-25       Impact factor: 29.690

4.  Long-Term Results of Bilateral Pulmonary Artery Banding Versus Primary Norwood Procedure.

Authors:  Yasutaka Hirata; Hiroaki Miyata; Norimichi Hirahara; Arata Murakami; Hideaki Kado; Kisaburo Sakamoto; Shunji Sano; Shinichi Takamoto
Journal:  Pediatr Cardiol       Date:  2017-09-21       Impact factor: 1.655

Review 5.  A Narrative Review of Postoperative Anticoagulation Therapy for Congenital Cardiac Disease.

Authors:  Alexander A Boucher; Julia A Heneghan; Subin Jang; Kaitlyn A Spillane; Aaron M Abarbanell; Marie E Steiner; Andrew D Meyer
Journal:  Front Surg       Date:  2022-06-14

6.  Post-operative Anticoagulation Strategy Following Comprehensive Stage 2 Procedure for Single Ventricle Physiology.

Authors:  Colleen Cloyd; Emma L Wysocki; Hunter Johnson; Julie C Miller; Joann Davis; Mark Galantowicz; Andrew R Yates
Journal:  Pediatr Cardiol       Date:  2022-03-26       Impact factor: 1.838

Review 7.  Hypoplastic Left Heart: Stage-I Will be Performed Interventionally, Soon.

Authors:  Dietmar Schranz; Anoosh Esmaeili; Hakan Akintuerk
Journal:  Pediatr Cardiol       Date:  2021-04-19       Impact factor: 1.655

8.  Apples to oranges: Making sense of hybrid palliation for hypoplastic left heart syndrome.

Authors:  Travis J Wilder; Christopher A Caldarone
Journal:  JTCVS Open       Date:  2020-10-15

Review 9.  Resource and cost considerations in treating hypoplastic left heart syndrome.

Authors:  Miguel Urencio; Chris Greenleaf; Jorge D Salazar; Ali Dodge-Khatami
Journal:  Pediatric Health Med Ther       Date:  2016-11-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.